03/12/2026 | News release | Distributed by Public on 03/12/2026 15:29
When rheumatology fellow Dr. Hira Imran meets one of her lupus nephritis patients, she knows the greatest challenge ahead of them will be figuring out which treatment will work best.
The second-year fellow specializes in autoimmune diseases like lupus. And she's improving the ability to pinpoint the most effective biologic therapy for each patient because of her research.
"I needed to see which out of the five drugs is the better among all five of them," says Hira Imran, MD. "This is what a network meta-analysis is."
Read more on the UT Health Sciences News website.